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Potential Renal Stone Outcomes 

•  Infection
•  Obstruction
•  Incapacitation
•  Mission failure
•  Evacuation
•  Long-term disability
•  Death

Space Flight Risk 
Factors 
•  Fluid shifts in microgravity
•  Bone demineralization
•  Decreased thirst and fluid intake
•  Concentrated urine
•  Calcium excretion
Whitson, P. (2001), The risk of renal stone formation during and 
after long-duration spaceflight, Nephron, 89(3):264-70.
Current ISS Medical 
Standards 
Renal stone is a disqualifying medical condition for 
long duration space flight  
•  Presence or history of urinary calculus 
•  Requires a medical waiver
History of Renal Stones in Space Flight 
•  U.S. Space Program
•  14 renal stone events among 12 astronauts as of 
2008
•  4 events prior to space flight (no association)
•  10 events within 2 years postflight

•  Russian Space Program 
•  3 renal stone events postflight
•  1 renal stone event inflight
Inflight Renal Stone Event 
•  Acute abdominal pain in a cosmonaut on 11/11/82 on 
Salyut 7 (6 months into a 7 month mission)
•  Initially diagnosed as appendicitis
•  Caused severe pain and significantly impacted the 
inflight timeline
•  Resolved on-orbit with apparent passing of the stone 
spontaneously over a period of days
•  No medical evacuation 
•  Mission was completed
Renal Stone Epidemiology 
•  Lifetime prevalence 10% male, 5% female
•  3.7 % to 4.6% of commercial aviation 
pilots between 2000 – 2007*
•  Similar to astronaut prevalence
*Hyams, E., et al. (2011) The incidence of urolithiasis among  
commercial aviation pilots, J Uro, 186:914-916.
Size 
(mm)
Stone 
Free
Progression Intervention
< 5 28% 40.4% 5.3%
5 - 10 4.8% 52.4% 9.5%
> 10 0% 71.4% 14.3%
Koh, et al. (2011), Outcomes of long-term follow-up of patients with conservative 
management of asymptomatic renal calculi, BJU Int,109:622-625.
Asymptomatic Stones 
Size vs. Spontaneous Passage 
Ueno, et al. (1977) Relation of spontaneous passage of ureteral caliculi to size.    J Urol, 10
(6):544-546.
Days to Pass vs. Size 
Miller, O. & Kane, C. (1999), Time to stone passage for observed ureteral 
caliculi: A guide for patient education, J Uro, 162:688-691.
Class 1 Medical Event Class 2 Medical Event Class 3 Medical Event Class 4 Medical Event
Medical problem with 
potential long-term 
health risk to individual 
but minimal symptoms 
or signs during mission
Significant  medical 
event, illness, or injury
Major medical illness or 
injury requiring full 
medical resource 
intervention
Acute medical crisis 
beyond ISS medical 
resource capabilities
May cause a moderate 
reduction in 
performance
Significant reduction in 
performance
Major degredation in 
performance Loss of critical function
Can handle with 
onboard capabilities
Requires extensive 
medical resource 
utilization
Full utilization of all 
available medical 
resources
Beyond capability of 
ISS medical resources
Can handle within 
designated timeline
May cause failure to 
meet mission objectives
Planned decrewing 
(medical evacuation) Emergency evacuation
Medical Risk Matrix – Long-Duration Missions (ISS)
MDC-1
MSMB Risk-based Decision Analysis


Low risk – acceptable for MDC 1 disposition (long duration)
Moderate risk – Further consideration required for an MDC 1 disposition
High risk – unsuitable for MDC 1 disposition
Likely ≥2%<5%
Possible ≥1%<2%
Unlikely <1%≥0.5%
Highly unlikely <0.5%

?
Renal Stone 
Risk


Integrated Medical Model 
(IMM) 
•  IMM Background
•  Software model used to simulate human space flight missions
•  Simulates medical events during space flight missions
•  Estimates the impact of these medical events on crew health and 
mission success
•  Outputs include estimates of crew health, probability of medical 
evacuation, and probability of medical loss of crew life
•  Optimization routines can be used to design medical systems which 
maximize crew health and probability of mission success

IMM Conceptual Model 
 Inputs

§  Medical 
Conditions & 
Incidence Data 

§  Crew Profile

§  Mission Profile & 
Constraints

§  Potential Crew 
Impairments

§  Potential Mission 
End States

§  In-flight Medical 
Resources

Integrated
Medical 
Model

Outputs


§  Medical Condition 
Occurrences

§  Crew Impairments

§  Clinical End States

§  Mission End States

§  Resource Utilization

§  Optimized Medical System
Class 1 Medical Event Class 2 Medical Event Class 3 Medical Event Class 4 Medical Event
Medical problem with 
potential long-term 
health risk to individual 
but minimal symptoms 
or signs during mission
Significant  medical 
event, illness, or injury
Major medical illness or 
injury requiring full 
medical resource 
intervention
Acute medical crisis 
beyond ISS medical 
resource capabilities
May cause a moderate 
reduction in 
performance
Significant reduction in 
performance
Major degredation in 
performance Loss of critical function
Can handle with 
onboard capabilities
Requires extensive 
medical resource 
utilization
Full utilization of all 
available medical 
resources
Beyond capability of 
ISS medical resources
Can handle within 
designated timeline
May cause failure to 
meet mission objectives
Planned decrewing 
(medical evacuation) Emergency evacuation
Medical Risk Matrix – Long-Duration Missions (ISS)
MDC-1
MSMB Risk-based Decision Analysis


Low risk – acceptable for MDC 1 disposition (long duration)
Moderate risk – Further consideration required for an MDC 1 disposition
High risk – unsuitable for MDC 1 disposition
Likely ≥2%<5%
Possible ≥1%<2%
Unlikely <1%≥0.5%
Highly unlikely <0.5% Renal Stone (<5mm) Renal Stone (>5mm)
Astronaut 
with no 
history of
stones
IMM Analysis 








Six month ISS mission with 6 crew
- with all crew meeting current med standards
•  Evacuation
1.  Visual Impairment
2.  Dental Abscess
3.   Kidney Stone
4.  Sepsis
5.  Smoke Inhalation

Three Scenarios 
1.  No history of stone
2.  History of stone
3.  Current stone
Hypothetical Case #1 
•  38 year old female Astronaut
•  No stone history
•  No findings on imaging
•  Will launch in 2 months to the ISS
•  For a 6 month mission
Risk of developing first stone?
Hypothetical Case #2 
•  45 year old male Cosmonaut
•  History of symptomatic 5 mm stone
•  Treated with lithotripsy, resolved
•  Will launch in 2 months to the ISS
•  For a 6 month mission
Risk of developing a new stone?
Hypothetical Case #3 
•  42 year old male Astronaut
•  2 mm calcification in renal parenchyma
•  Asymptomatic
•  Will launch in 2 months to the ISS for a 6 
month mission
Risk of becoming symptomatic?
Risk Quantification 
•  IMM can provide renal stone risk estimates that 
can be used to assist  
•  Crew medical certification decisions
•  Medical resource allocation
•  Crew medical training
Renal Stone Issues 
Renal stones are a low likelihood but high 
consequence event
•  What are acceptable waiver criteria?
•  Can renal stone events be prevented?
•  How do we monitor for stone formation 
pre-flight and in-flight?
•  How do we manage in-flight stones?
Future Work 
•  Improved risk assessment
•  Prevention
•  Close monitoring and early detection
•  Improved treatments
•  Creation of a NASA Renal Stone Clinical 
Practice Guideline  

